Not Medicare Enrolled

Dr. Joseph Rizzo, M.D.

Cardiovascular Disease · Lubbock, TX
Low-engagement
4802 N LOOP 289, Lubbock, TX 79416
8067880040
In practice since 2005 (20 years)
NPI: 1104829639 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rizzo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rizzo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rizzo

Dr. Joseph Rizzo is a cardiovascular disease in Lubbock, TX, with 20 years in practice.

Between the years covered by Open Payments, Dr. Rizzo received a total of $4,824 from 26 pharmaceutical and/or device companies across 317 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rizzo is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice$ $4,824 industry payments

Industry Payment Transparency

Open Payments through 2023 ↗
$4,824
Total received (2018-2023)
Avg $804/year across 6 years
Top 50% in TX for cardiovascular disease
26
Companies
317
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,688 (97.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$136 (2.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$120
2022
$57
2021
$69
2020
$1,150
2019
$1,891
2018
$1,537

Payments by company (2023)

Consulting
Speaking
Meals & Travel
Research
Medtronic Vascular, Inc.
$635
Amgen Inc.
$628
Boston Scientific Corporation
$589
Amarin Pharma Inc.
$497
Abbott Laboratories
$333
Kowa Pharmaceuticals America, Inc.
$291
Edwards Lifesciences Corporation
$270
Gilead Sciences, Inc.
$208
Janssen Pharmaceuticals, Inc
$207
AstraZeneca Pharmaceuticals LP
$202
E.R. Squibb & Sons, L.L.C.
$171
Medtronic, Inc.
$132
ABIOMED
$112
Boehringer Ingelheim Pharmaceuticals, Inc.
$111
BOSTON SCIENTIFIC CORPORATION
$110
Cardinal Health 200, LLC
$66
SANOFI-AVENTIS U.S. LLC
$61
PFIZER INC.
$41
Philips Electronics North America Corporation
$40
Actelion Pharmaceuticals US, Inc.
$37
Allergan Inc.
$18
Novo Nordisk Inc
$16
Alnylam Pharmaceuticals Inc.
$16
W. L. Gore & Associates, Inc.
$15
Tactile Systems Technology Inc
$13
Bardy Diagnostics, Inc.
$6
Top 3 companies account for 38.4% of total payments
Associated products mentioned in payments ›
APEX · AVANTI Sheath Introducer · Advisa · BRILINTA · BYSTOLIC · COREVALVE EVOLUT R · Carnation Ambulatory Monitor · CoreValve Evolut · Corlanor · ELIQUIS · ELUVIA · EluNIR Radaforolimus Eluting Coronary Stent System · Endurant · FARXIGA · FLEXITOUCH · GENERAL THERAPIES · GENERAL VASCULAR INTERVENTION · GENERAL METALLIC STENTS · GUIDEZILLA · HawkOne · HeartMate · Hi-Torque Balance Guide Wires · IGT D Service Syst · IN.PACT Admiral · Impella · JARDIANCE · Livalo · MOZEC TM · MULTAQ · MynxGrip Vascular Closure Device · NC TREK coronary catheters · ONPATTRO · ONYX FRONTIER · OPSUMIT · OPSUMIT MACITENTAN · PRADAXA · Perclose ProGlide suture mediated closure system · Repatha · Resolute · SYNERGY · Supera peripheral stent system · VIABAHN VBX Balloon Expandable Endoprosthesis · Vascepa · Viance · WALLSTENT · WOLVERINE · Wegovy · Wolverine Coronary Cutting Balloon · XARELTO · Xience Alpine cornary stent system
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a cardiovascular disease in Lubbock?
Compare cardiovascular diseases in the Lubbock area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
19
Per 100K population
6.0
County median income
$63,367
Nearest hospital
LUBBOCK HEART HOSPITAL LP
0.0 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment— Not enrolledN/A
Practice Data— No dataN/A
Industry Payments✓ Open PaymentsCY 2023
Disciplinary History— Not publicN/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rizzo is a cardiovascular disease, and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Rizzo receive payments from pharmaceutical companies?
Yes. Dr. Rizzo received a total of $4,824 from 26 companies across 317 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Rizzo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Cardiovascular Diseases in Lubbock
Browse cardiovascular diseases in Lubbock ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →